Literature DB >> 7398746

Placental transfer and pharmacokinetics of primidone and its metabolites phenobarbital, PEMA and hydroxyphenobarbital in neonates and infants of epileptic mothers.

H Nau, D Rating, I Häuser, E Jäger, S Koch, H Helge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7398746     DOI： 10.1007/bf00561476

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  20 in total

1.  Placental transfer of phenobarbitone in epileptic women, and elimination in newborns.

Authors:  J C Melchior; O Svensmark; D Trolle
Journal:  Lancet       Date:  1967-10-21       Impact factor: 79.321

2.  The fate of aminopyrine (pyramidon) in man and methods for the estimation of aminopyrine and its metabolites in biological material.

Authors:  B B BRODIE; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1950-06       Impact factor: 4.030

3.  Lack of hepatic enzyme inducing effect of sodium valproate.

Authors:  J Oxley; A Hedges; K A Makki; A Monks; A Richens
Journal:  Br J Clin Pharmacol       Date:  1979-08       Impact factor: 4.335

4.  Transplacental passage of primidone.

Authors:  G Martinez; R D Snyder
Journal:  Neurology       Date:  1973-04       Impact factor: 9.910

5.  Metabolic disposition of primidone and its metabolites in epileptic subjects after single and repeated administration.

Authors:  B B Gallagher; I P Baumel; R H Mattson
Journal:  Neurology       Date:  1972-11       Impact factor: 9.910

6.  Drug metabolism in epileptics: in vivo and in vitro correlations.

Authors:  E A Sotaniemi; R O Pelkonen; J Ahokas; H I Pirttiaho; J Ahlqvist
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

7.  Blood levels of drug at the equilibrium state after multiple dosing.

Authors:  J G Wagner; J I Northam; C D Alway; O S Carpenter
Journal:  Nature       Date:  1965-09-18       Impact factor: 49.962

8.  Phenobarbital pharmacokinetics in neonates.

Authors:  W Pitlick; M Painter; C Pippenger
Journal:  Clin Pharmacol Ther       Date:  1978-03       Impact factor: 6.875

9.  Phenylethylmalonamide (PEMA). An important metabolite of primidone.

Authors:  I P Baumel; B B Gallagher; R H Mattson
Journal:  Arch Neurol       Date:  1972-07

10.  Teratogenic and pharmacokinetic studies of primidone during pregnancy and in the offspring of epileptic women.

Authors:  D Rating; H Nau; E Jäger-Roman; I Göpfert-Geyer; S Koch; G Beck-Mannagetta; D Schmidt; H Helge
Journal:  Acta Paediatr Scand       Date:  1982-03
View more
  13 in total

Review 1.  The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state.

Authors:  M D Hill; F P Abramson
Journal:  Clin Pharmacokinet       Date:  1988-03       Impact factor: 6.447

Review 2.  Anticonvulsants during pregnancy and lactation. Transplacental, maternal and neonatal pharmacokinetics.

Authors:  H Nau; W Kuhnz; H J Egger; D Rating; H Helge
Journal:  Clin Pharmacokinet       Date:  1982 Nov-Dec       Impact factor: 6.447

3.  Anticonvulsants in the newborn period.

Authors:  N Buchanan
Journal:  Indian J Pediatr       Date:  1985 Sep-Oct       Impact factor: 1.967

Review 4.  Lactation studies of anticonvulsants: a quality review.

Authors:  Douwe H van der Meer; Andre Wieringa; Ilse Wegner; Bob Wilffert; Peter G J Ter Horst
Journal:  Br J Clin Pharmacol       Date:  2015-04       Impact factor: 4.335

Review 5.  Placental transfer of drugs administered to the mother.

Authors:  G M Pacifici; R Nottoli
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

6.  The disposition of primidone in elderly patients.

Authors:  C Martines; G Gatti; E Sasso; S Calzetti; E Perucca
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

Review 7.  Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.

Authors:  C L Harden; P B Pennell; B S Koppel; C A Hovinga; B Gidal; K J Meador; J Hopp; T Y Ting; W A Hauser; D Thurman; P W Kaplan; J N Robinson; J A French; S Wiebe; A N Wilner; B Vazquez; L Holmes; A Krumholz; R Finnell; P O Shafer; C Le Guen
Journal:  Neurology       Date:  2009-04-27       Impact factor: 9.910

8.  Placental transfer of etozolin and ozolinone during the first half of gestation in man.

Authors:  H Nau; R Steldinger; E Ivan
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 9.  Management of epilepsy during pregnancy.

Authors:  Dina Battino; Torbjörn Tomson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Ethosuximide in epileptic women during pregnancy and lactation period. Placental transfer, serum concentrations in nursed infants and clinical status.

Authors:  W Kuhnz; S Koch; S Jakob; A Hartmann; H Helge; H Nau
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.